2021-2026 
RCB: 202-A02326-33
Better characterization of pregnancy pathologies from implantation to delivery, through the comparison of frequencies (in percentage) of histological differences of the placenta and its appendages in patients with pathological and normal pregnancies (histological differences of normal vs pathological pregnancies)
Investigators: Pr. Pascale Hoffmann (CHU de Grenoble) & Dr. Nadia Alfaidy (Inserm U1292)
NCT01490489
The purpose of this study is to evaluate the potential prognostic value of serum EG-VEGF levels for preeclampsia and/or intrauterine growth retardation and will test whether plasma EG-VEGF levels at 14-18 weeks of gestation could be proposed as a prognostic marker for preeclampsia.
Investigators: Pr. Pascale Hoffmann (CHU de Grenoble) & Dr. Nadia Alfaidy (Inserm U1292)